Metformin does not adversely affect hormonal and symptomatic responses to recurrent hypoglycemia

被引:15
作者
Fruehwald-Schultes, B
Kern, W
Oltmanns, KM
Sopke, S
Toschek, B
Born, J
Fehm, HL
Peters, A
机构
[1] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany
[2] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany
关键词
D O I
10.1210/jc.86.9.4187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Body weight gain and severe hypoglycemia are the major adverse effects of insulin therapy in type 2 diabetic patients. Metformin has been shown to prevent insulin therapy-induced body weight gain when used in combination with insulin. However, the effects of metformin on hormonal and symptomatic responses to hypoglycemia mediating hypoglycemia awareness have not been assessed to date. Fifteen young healthy men were treated with 850 mg metformin and placebo twice daily for a 16-d period in a double blind, crossover design. On the last 2 d of the treatment period, the subjects underwent three hypoglycemic clamp experiments, with the first and the last performed with identical patterns of plasma glucose decrease. Differences between the effects of metformin and placebo (effect of metformin) as well as between first and last hypoglycemic clamps (effect of antecedent hypoglycemia) were assessed. Antecedent hypoglycemia significantly reduced epinephrine, ACTH, cortisol, glucagon, GH, and symptomatic responses to hypoglycemia (P < 0.05 for all variables). There was no detectable effect of metformin on epinephrine, norepinephrine, ACTH, cortisol, glucagon, or autonomic symptomatic response to hypoglycemia (P > 0.05 for all comparisons), except that metformin slightly increased the response of GH to hypoglycemia (P = 0.039). The latter finding may be due to an IGF-I-reducing effect of metformin, as after 14 d of metformin treatment baseline levels of IGF-l were significantly lower than in the placebo condition (236.9 +/- 13.9 vs. 263.2 +/- 14.4 mug/liter; P = 0.015). The data indicate that metformin does not adversely affect hormonal and symptomatic responses to hypoglycemia. This finding appears to be relevant with regard to the safety of the combination of metformin with insulin therapy.
引用
收藏
页码:4187 / 4192
页数:6
相关论文
共 42 条
[1]  
ALENGRIN F, 1987, DIABETES METAB, V13, P591
[2]   Cardiovascular actions of chronic intracerebroventricular administration of metformin in normotensive rats [J].
Andersen, D ;
Haugan, K ;
Sorensen, AM ;
Christensen, S ;
Petersen, JS .
PHARMACOLOGY & TOXICOLOGY, 1997, 81 (01) :7-12
[3]   Effects of metformin in patients with poorly controlled insulin-treated type 2 diabetes mellitus -: A randomized, double-blind, placebo-controlled trial [J].
Avilés-Santa, L ;
Sinding, J ;
Raskin, P .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (03) :182-+
[4]  
Bailey CJ, 2000, DIABETIC MED, V17, P83
[5]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[6]   Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM - Evidence for a nonselective defect [J].
Bottini, P ;
Boschetti, E ;
Pampanelli, S ;
Ciofetta, M ;
DelSindaco, P ;
Scionti, L ;
Brunetti, P ;
Bolli, GB .
DIABETES, 1997, 46 (05) :814-823
[7]   Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus [J].
Boyle, PJ ;
Kempers, SF ;
OConnor, AM ;
Nagy, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1726-1731
[8]   GROWTH-HORMONE, CORTISOL, OR BOTH ARE INVOLVED IN DEFENSE AGAINST, BUT ARE NOT CRITICAL TO RECOVERY FROM, HYPOGLYCEMIA [J].
BOYLE, PJ ;
CRYER, PE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :E395-E402
[9]   Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects -: The BIGPRO1 study [J].
Charles, MA ;
Morange, P ;
Eschwège, E ;
André, P ;
Vague, P ;
Juhan-Vague, I .
DIABETES CARE, 1998, 21 (11) :1967-1972
[10]   COUNTERREGULATORY ADAPTATION TO RECURRENT HYPOGLYCEMIA IN NORMAL HUMANS [J].
DAVIS, MR ;
SHAMOON, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05) :995-1001